Crinetics Pharmaceuticals (CRNX) Current Ratio
Price: $32.39
Market Cap: $3.01B
Avg Volume: 1.01M
Market Cap: $3.01B
Avg Volume: 1.01M
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Crinetics Pharmaceuticals Current Ratio
- Annual: 23.04
- Quarterly: 23.04
- TTM: 23.04
What is the Current Ratio?
The current ratio is a liquidity ratio that measures a company's ability to pay off its short-term liabilities with its short-term assets. A higher current ratio indicates a greater ability to meet short-term obligations.
Related Metrics
Other important metrics to assess Crinetics Pharmaceuticals's financial health include:
- Quick Ratio - measures the company's ability to meet short-term obligations with its most liquid assets:
- Annual: 23.04
- Quarterly: 23.04
- TTM: 23.04
- Cash Ratio - measures the company's ability to pay off short-term liabilities with cash and cash equivalents:
- Annual: 4.43
- Quarterly: 4.43
- TTM: 4.43
These metrics provide insights into Crinetics Pharmaceuticals's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.
Annual Current Ratio
23.04
Quarterly Current Ratio
23.04
TTM Current Ratio
23.04
Crinetics Pharmaceuticals Historical Current Ratio
Historical Quick Ratio
Historical Cash Ratio
Crinetics Pharmaceuticals Historical Ratios
The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | Current Ratio | Quick Ratio | Cash Ratio |
|---|---|---|---|
| 2024 | 23.04 | 23.04 | 4.43 |
| 2023 | 13.07 | 13.07 | 1.25 |
| 2022 | 12.45 | 12.45 | 1.18 |
| 2021 | 21.55 | 21.05 | 12.55 |
| 2020 | 16.92 | 17.10 | 8.87 |
| 2019 | 14.79 | 14.95 | 4.84 |
| 2018 | 21.03 | 21.03 | 5.67 |
| 2017 | 16.91 | 16.75 | 15.82 |
| 2016 | 13.89 | 13.78 | 13.65 |
Related Metrics
Explore detailed financial metrics and analysis for CRNX.